• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Hyperion Therapeutics

edit

Hyperion is a biotech company developing therapies to address “orphan or underserved patient populations.” They are located in South San Francisco, CA.

Milestones

edit

• 
  Hyperion Therapeutics received $13M in Debt funding. (5/18/09)
  Posted 9/23/09 at 3:01pm via venturebeat.com
• 
  Hyperion Therapeutics received $40M in Series B funding. (9/5/07)
  Posted 9/17/09 at 8:25am via venturebeat.com
• 
  Hyperion Therapeutics received $15M in Debt funding. (10/4/07)
  Posted 9/15/09 at 2:12am via venturebeat.com
• 
  Hyperion Therapeutics received $60M in Series C funding. (6/30/09)
  Posted 6/30/09 at 3:34pm via fiercebiotech.com
• 
  Hyperion Therapeutics — Raised $17.5 million from existing investors (4/1/11)
  Posted 5/6/11 at 6:55am

Videos

Screenshots

edit

Sources

1. Hyperion Therapeutics raises $40M against GI and kidney disease (deals.venturebeat.com) [edit]
2. Specialty pharma Hyperion raises $15M in debt, names execs (deals.venturebeat.com) [edit]
3. Hyperion brings in $13M for gastrointestinal relief (deals.venturebeat.com) [edit]
4. Hyperion lands $60M VC round (fiercebiotech.com) [edit]
5. Citation Needed [add]